Clinical unmet needs

• Obesity is a chronic disease characterized by excessive accumulation of fat due to an imbalance between energy
  take and energy expenditure.
• There are three main pharmacological strategies for obesity treatment: Suppressing appetite, Impairing absorption,
  and Increasing energy expenditure. Long-term use-approved drugs for weight management possess mechanisms
  that suppress appetite or inhibit fat absorption to control weight. However, there are currently no approved drugs
  with a mechanism that increases energy metabolism to induce weight loss.
• Oxyntomodulin analogue can regulate body weight not only by suppressing appetite but also by increasing energy
  expenditure. Therefore, it is expected to be the next generation of obesity treatments with a mechanism that
  induces weight loss based on energy consumption, which can meet the unmet needs in the market.